$RILYP
Great American Group, Inc.
CIK:0001464790|SEC Filings
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands |
6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
||||||
| Cash flows from operating activities | |||||||
| Net income | [1] | $ 243,756 | $ 124,432 | ||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||||
| Depreciation and amortization | [1] | 15,137 | 18,798 | ||||
| Provision for losses on accounts receivable | [1] | 873 | 1,614 | ||||
| Share-based compensation | [1] | 5,666 | 8,606 | ||||
| Fair value and remeasurement adjustments ($(56) and $3,011 from related parties) | [1] | (6,461) | (6,789) | ||||
| Non-cash interest and other (includes $— and $(268) from related parties) | [1] | 3,516 | 6,584 | ||||
| Depreciation of rental merchandise | [1] | 6,094 | 6,698 | ||||
| Net foreign currency losses (gains) | [1] | 18 | (481) | ||||
| Loss (income) from equity investments | [1] | 4,133 | (25,051) | ||||
| Dividends from equity investments | [1] | 273 | 122 | ||||
| Deferred income taxes | [1] | 502 | 9,100 | ||||
| Impairment of tradename | [1] | 4,000 | 1,500 | ||||
| Gain on disposal of discontinued operations | [1] | 0 | (66,795) | ||||
| Loss (gain) on sale or disposal of fixed assets and other | [1] | 143 | (1,147) | ||||
| Gain on sale and deconsolidation of businesses | [1] | 0 | (86,213) | ||||
| (Gain) loss on extinguishment of debt | [1] | (1,607) | 20,693 | ||||
| Gain on senior note exchange | [1] | 0 | (54,986) | ||||
| Change in operating assets and liabilities: | |||||||
| Amounts due to/from clearing brokers | [1] | 19,294 | (14,668) | ||||
| Securities and other investments owned | [1] | (278,602) | 39,126 | ||||
| Securities borrowed | [1] | (91,780) | (29,298) | ||||
| Accounts receivable | [1] | (6,784) | 3,542 | ||||
| Prepaid expenses and other assets ($— and $3,373 from related parties) | [1] | 11,080 | 6,728 | ||||
| Accounts payable, accrued expenses and other liabilities | [1] | 2,005 | (13,665) | ||||
| Amounts due to/from related parties and partners | [1] | 0 | (2,290) | ||||
| Securities sold not yet purchased | [1] | (322) | 6,672 | ||||
| Deferred revenue | [1] | (2,922) | (4,609) | ||||
| Securities loaned | [1] | 91,871 | 26,402 | ||||
| Net cash provided by (used in) operating activities | [1] | 19,883 | (25,375) | ||||
| Cash flows from investing activities | |||||||
| Purchases of loans receivable ($— and $50,853 from related parties) | [1] | (44,192) | (66,650) | ||||
| Repayments of loans receivable ($1,855 and $50,883 by related parties) | [1] | 44,403 | 105,378 | ||||
| Proceeds from sale of loans receivable ($— and $6,611 from related parties) | [1] | 0 | 10,415 | ||||
| Proceeds from loan participations sold | [1] | 0 | 4,475 | ||||
| Proceeds from sale of business, net of cash sold and other | [1] | 0 | 94,938 | ||||
| Purchases of property, equipment, and intangible assets | [1] | (2,241) | (9,148) | ||||
| Proceeds from sale of property, equipment, intangible assets, and other | [1] | 0 | 7,173 | ||||
| Distributions from equity investments | [1] | 1,210 | 34,869 | ||||
| Purchases of equity and other investments | [1] | 0 | (6,621) | ||||
| Consolidation of VIE | [1] | 0 | 359 | ||||
| Proceeds from sale of discontinued operations, net of cash sold | [1] | 0 | 114,032 | ||||
| Net cash (used in) provided by investing activities | [1] | (820) | 289,220 | ||||
| Cash flows from financing activities | |||||||
| Proceeds from revolving lines of credit | [1] | 108,077 | 46,374 | ||||
| Repayment of revolving lines of credit | [1] | (83,399) | (50,627) | ||||
| Proceeds from note payable | [1] | 0 | 850 | ||||
| Repayment of notes payable and other | [1] | (592) | (13,138) | ||||
| Repayment of term loans | [1] | (6,250) | (310,253) | ||||
| Proceeds from term loans | [1] | 0 | 235,550 | ||||
| Redemption of senior notes, net | [1] | (90,594) | (145,302) | ||||
| Repurchases and payments on senior notes | [1] | (13,122) | 0 | ||||
| Payment of debt issuance and offering costs | [1] | (441) | (11,253) | ||||
| Payment of contingent consideration | [1] | 0 | (1,376) | ||||
| Payment of employment taxes on vesting of restricted stock | [1] | (2,831) | 0 | ||||
| Distributions to noncontrolling interests | [1] | (1,358) | (3,249) | ||||
| Net cash used in financing activities | [1] | (90,510) | (252,424) | ||||
| Increase in cash, cash equivalents and restricted cash | [1] | (71,447) | 11,421 | ||||
| Effect of foreign currency on cash, cash equivalents and restricted cash | [1] | (2,188) | 546 | ||||
| Net decrease in cash and cash equivalents | [1] | (73,635) | 11,967 | ||||
| Cash, cash equivalents and restricted cash from continuing operations, beginning of period | 229,277 | 248,651 | |||||
| Cash, cash equivalents and restricted cash from discontinued operations, beginning of period | 0 | 8,025 | |||||
| Cash, cash equivalents and restricted cash, total | 155,642 | 268,643 | |||||
| Cash, cash equivalents and restricted cash from continuing operations, end of period | 155,642 | 268,643 | |||||
| Cash, cash equivalents and restricted cash from discontinued operations, end of period | 0 | 0 | |||||
| Reconciliation of cash, cash equivalents and restricted cash to amounts reported in the condensed consolidated balance sheets: | |||||||
| Cash and cash equivalents | 154,112 | [2] | 267,388 | ||||
| Restricted cash | 1,530 | 1,255 | |||||
| Total cash, cash equivalents and restricted cash | 155,642 | 268,643 | |||||
| Supplemental disclosure of cash flow information: | |||||||
| Interest paid | 38,418 | 55,011 | |||||
| Taxes paid | 838 | 2,139 | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||
| Transfer of loans to held for sale from loans receivable at fair value | 0 | 8,876 | |||||
| Issuance of common stock in equity of subsidiary | 0 | 1,575 | |||||
| Issuance of warrants for term loan | 0 | 7,860 | |||||
| Recognition of derivative liability for term loan springing maturity | 797 | 0 | |||||
| Recognition of derivative liability for term loan exit fee | 0 | 11,244 | |||||
| Disposition of noncontrolling interests through sale and deconsolidation of businesses | 0 | 2,918 | |||||
| Capital from noncontrolling interest upon initial consolidation of VIE | 0 | 12,494 | |||||
| Reclassification of restricted stock units from liability to equity | 2,589 | 0 | |||||
| Reclassification of restricted stock units from equity to liability | 0 | 2,138 | |||||
| Issuance of common stock in connection with redemption of senior notes | 67,785 | 0 | |||||
| Issuance of warrants | 0 | 1,600 | |||||
| Settlement of warrant liability upon cashless exercise | 9,400 | 0 | |||||
| Exchange of preferred stock investment for loan receivable | $ 1,198 | $ 0 | |||||
| |||||||
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
||
|---|---|---|---|---|
| Assets: | ||||
| Cash and cash equivalents | [1] | $ 154,112 | $ 226,601 | |
| Restricted cash | 1,530 | 2,676 | ||
| Due from clearing brokers | 31,706 | 51,000 | ||
| Securities and other investments owned ($660,185 and $382,461 at fair value) | [1] | 723,715 | 446,843 | |
| Securities borrowed | 206,717 | 114,937 | ||
| Accounts receivable, net of allowance for credit losses of $6,209 and $6,108 | 61,382 | 55,473 | ||
| Loans receivable, at fair value ($1,035 and $2,835 from related parties) | 38,802 | 26,303 | ||
| Equity investments | 84,817 | 90,433 | ||
| Prepaid expenses and other assets | [1] | 110,862 | 128,650 | |
| Operating lease right-of-use assets | 38,476 | 32,109 | ||
| Property and equipment, net | 17,850 | 17,606 | ||
| Goodwill | 392,687 | 392,687 | ||
| Other intangible assets, net | 101,867 | 118,290 | ||
| Deferred income taxes | 794 | 763 | ||
| Total assets | 1,967,538 | 1,706,592 | ||
| Liabilities: | ||||
| Accounts payable | 35,475 | 41,463 | ||
| Accrued expenses and other liabilities ($797 and $6,400 at fair value) | [1] | 156,333 | 154,780 | |
| Deferred revenue | 46,985 | 49,907 | ||
| Deferred income taxes | 4,642 | 4,109 | ||
| Securities sold not yet purchased, at fair value | 9,487 | 9,809 | ||
| Securities loaned | 189,192 | 97,321 | ||
| Operating lease liabilities | 46,307 | 40,902 | ||
| Revolving credit facilities | 31,316 | 6,638 | ||
| Term loans, net | 115,770 | 119,297 | ||
| Senior notes payable, net | 1,129,966 | 1,301,798 | ||
| Total liabilities | 1,766,303 | 1,826,854 | ||
| Commitments and contingencies (Note 26) | ||||
| BRC Group Holdings, Inc. stockholders’ equity (deficit): | ||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 4,563 shares issued and outstanding and liquidation preference of $126,172 and $122,142 | 0 | 0 | ||
| Common stock, $0.0001 par value; 100,000,000 shares authorized; 40,199,755 and 30,597,066 issued and outstanding | 4 | 3 | ||
| Additional paid-in capital | 680,097 | 598,022 | ||
| Accumulated deficit | (529,464) | (763,286) | ||
| Accumulated other comprehensive loss | (8,468) | (6,272) | ||
| Total BRC Group Holdings, Inc. stockholders’ equity (deficit) | 142,169 | (171,533) | ||
| Noncontrolling interest | [1] | 59,066 | 51,271 | |
| Total equity (deficit) | 201,235 | (120,262) | ||
| Total liabilities and equity (deficit) | 1,967,538 | 1,706,592 | ||
| Discontinued Operations, Disposed of by Sale | ||||
| Assets: | ||||
| Assets of discontinued operations (Note 4) | 2,221 | 2,221 | ||
| Liabilities: | ||||
| Liabilities of discontinued operations (Note 4) | $ 830 | $ 830 | ||
| ||||